FDA warns of nationwide Adderall shortage

Published

2 years ago

October 14, 2022

Holly Stearnes

FDA has released a warning to millions about a nation-wide Adderall shortage

The FDA says they’re experiencing a nation-wide Adderall shortage, a drug predominately used to treat ADHD.

The FDA says manufacturers across America are unable to meet consumer demands, causing the production line to cripple.

There has been a steep uptick in people using the medication recently, leaving some medical experts wondering why.

Supplies will not return to normal until 2023 with the administration advising people to look for alternative therapies in the meantime.

Related Topics:Adderall america trending us

Up Next

Why WhatsApp’s 3D ad is going viral

Don't Miss

Shares in the Tokyo-based company climb amid buyout rumours

Holly Stearnes

Why the meme-stock frenzy is unlikely to repeat

Published

3 days ago

May 14, 2024

Nathan Langridge

GME shares surge 74%, but experts stress a meme-stock frenzy resurgence is unlikely due to fundamental differences in the company’s financial situation.

Australia’s budget unveils a second consecutive surplus of A$9.3 billion, prioritising the critical minerals industry and green energy initiatives to reduce reliance on Chinese supply.

Also, GameStop shares have surged 74%, but experts caution against expecting a repeat of the 2021 meme-stock frenzy. #featured #trending

Money

Why are airlines after the Biden Administration?

Published

3 days ago

May 14, 2024

Nathan Langridge

Major airlines are taking legal action against the Biden administration over a newly implemented rule requiring them to disclose fees upfront.

On this episode of Hot Shots – Major airlines are suing the Biden Administration, AI-piloted fighter jets, SpaceX faces funding challenges, and Apple receives crushing feedback.

Ticker’s Ahron Young & Veronica Dudo discuss. #featured #trending

Money

The mounting pressure on Government spends

Published

4 days ago

May 13, 2024

ticker NEWS

Questions abound regarding the factors fueling this inflation surge in Australia and whether it correlates with the escalating government expenditures.

Concerns extend to how Chalmers navigates the mounting pressure amid discrepancies in spending allocations.

Moreover, as Australians grapple with the reality of rising living costs, the feasibility of cutting spending becomes a pressing issue. Additionally, amidst economic uncertainties, individuals seek guidance on managing stock market risks effectively. #Featured #Trending